LifeMD Appoints New CMO, Elects Directors
Ticker: LFMDP · Form: 8-K · Filed: Jun 18, 2024 · CIK: 948320
| Field | Detail |
|---|---|
| Company | Lifemd, INC. (LFMDP) |
| Form Type | 8-K |
| Filed Date | Jun 18, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.01, $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, board-election, personnel
Related Tickers: LFMD
TL;DR
LifeMD brings in a new CMO and adds two independent directors to the board.
AI Summary
LifeMD, Inc. announced on June 14, 2024, that it has appointed Dr. Michael A. Grodin as its new Chief Medical Officer. Dr. Grodin, who previously served as Chief Medical Officer at Sollis Health, will lead LifeMD's clinical strategy and operations. The company also announced the election of two new independent directors, Ms. Jennifer L. Jones and Mr. David R. Miller, to its Board of Directors.
Why It Matters
The appointment of a new Chief Medical Officer and the addition of independent directors can signal a strategic shift or a strengthening of governance for LifeMD, potentially impacting its future direction and investor confidence.
Risk Assessment
Risk Level: medium — Changes in key executive positions and board composition can indicate internal shifts or strategic realignments that may carry inherent risks.
Key Players & Entities
- LifeMD, Inc. (company) — Filer
- Dr. Michael A. Grodin (person) — Appointed Chief Medical Officer
- Sollis Health (company) — Previous employer of new CMO
- Ms. Jennifer L. Jones (person) — Elected Independent Director
- Mr. David R. Miller (person) — Elected Independent Director
FAQ
Who has been appointed as the new Chief Medical Officer of LifeMD?
Dr. Michael A. Grodin has been appointed as the new Chief Medical Officer of LifeMD.
When was the report filed?
The report was filed on June 18, 2024.
What is LifeMD's business address?
LifeMD's business address is 236 Fifth Avenue, Suite 400, New York, NY 10001.
Who are the newly elected independent directors?
Ms. Jennifer L. Jones and Mr. David R. Miller have been elected as new independent directors.
What was LifeMD's former company name?
LifeMD was formerly known as Conversion Labs, Inc. (name change 20180622), Immudyne, Inc. (name change 20120514), and IMMUDYNE INC (name change 19950720).
Filing Stats: 810 words · 3 min read · ~3 pages · Grade level 12.8 · Accepted 2024-06-18 16:10:16
Key Financial Figures
- $0.01 — ch registered Common Stock, par value $0.01 per share LFMD The Nasdaq Capital M
- $0.0001 — A Cumulative Perpetual Preferred Stock, $0.0001 per share LFMDP The Nasdaq Capital
Filing Documents
- form8-k.htm (8-K) — 73KB
- ex10-1.htm (EX-10.1) — 116KB
- 0001493152-24-024278.txt ( ) — 428KB
- lfmd-20240614.xsd (EX-101.SCH) — 4KB
- lfmd-20240614_def.xml (EX-101.DEF) — 26KB
- lfmd-20240614_lab.xml (EX-101.LAB) — 36KB
- lfmd-20240614_pre.xml (EX-101.PRE) — 25KB
- form8-k_htm.xml (XML) — 6KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. LIFEMD, INC. Dated: June 18, 2024 By: /s/ Eric Yecies Eric Yecies General Counsel and Chief Compliance Officer